Cuu Long Pharmaceutical JSC (HOSE: DCL)

Market Cap	1.92T
Revenue (ttm)	1.19T
Net Income (ttm)	63.49B
Shares Out	73.04M
EPS (ttm)	869.24
PE Ratio	30.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,100
Average Volume	258,740
Open	26,250
Previous Close	26,250
Day's Range	26,000 - 26,500
52-Week Range	23,200 - 32,000
Beta	0.72
RSI	48.68
Earnings Date	Jan 24, 2025

About HOSE: DCL

Cuu Long Pharmaceutical Joint Stock Company manufactures and distributes pharmaceutical products primarily in Vietnam. The company offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. It provides its products under various brands to hospitals, pharmacies, and drugstores through its distribution network, including branches and distributors. The comp...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 930
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2023, DCL's revenue was 1.14 trillion, an increase of 12.63% compared to the previous year's 1.02 trillion. Earnings were 61.72 billion, a decrease of -43.19%.